Quarterly performance at a glance
(Rs. in Crores)
Particulars - Advertisement - | Q3’FY 2020-21 | Q3’FY 2019-20 | % Growth |
Net Revenue | 310.26 | 234.66 | 32% |
EBIDTA | 32.63 | 19.91 | 64% |
Net Profit AfterTax (PAT) |
Morepen Labs Eyeing Multi-billion Dollar Global Market for New API Molecules going Off-patent in next 5-6 Years
